Computational methods that reliably predict the biological activities of compounds have long been sought. The validation of one such method suggests that in silico predictions for drug discovery have come of age.
This is a preview of subscription content, log in via an institution to check access.
References
Roth, B. L., Sheffler, D. J. & Kroeze, W. K. Nature Rev. Drug Discov. 3, 353–359 (2004).
Keiser, M. J. et al. Nature 462, 175–181 (2009).
Nigsch, F., Bender, A., Jenkins, J. L. & Mitchell, J. B. J. Chem. Inf. Model. 48, 2313–2325 (2008).
Keiser, M. J. et al. Nature Biotechnol. 25, 197–206 (2007).
Yildirim, M. A. et al. Nature Biotechnol. 25, 1119–1126 (2007).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hopkins, A. Predicting promiscuity. Nature 462, 167–168 (2009). https://doi.org/10.1038/462167a
Published:
Issue Date:
DOI: https://doi.org/10.1038/462167a
- Springer Nature Limited
This article is cited by
-
Explainable deep drug–target representations for binding affinity prediction
BMC Bioinformatics (2022)
-
Turbo prediction: a new approach for bioactivity prediction
Journal of Computer-Aided Molecular Design (2022)
-
Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target interactions
Molecular Diversity (2021)
-
A unified solution for different scenarios of predicting drug-target interactions via triple matrix factorization
BMC Systems Biology (2018)
-
Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice
Acta Pharmacologica Sinica (2018)